1 day Bristol Myers Stock Gains 11.4% in a Year: Time to Buy or Sell? Zacks

Bristol Myers stock has performed well in the past year, gaining 11%. We believe there is more room for further growth, and any dip in the share price can be used as a buying opportunity.

Biotech · Bristol · Bristol-Myers Squibb (BMY)

1 day Bristol Myers Stock Gains 11.4% in a Year: Time to Buy or Sell? Zacks

7 hours Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. Investor's Business Daily

1 day Top 5 Commercial Biotech Buyout Candidates: Mirum Pharmaceuticals (No. 3) Seeking Alpha

1 day There’s a ‘Shadow’ Over Biotech Stocks. Why It Isn‘t All Bad News. Yahoo Finance

2 days Amgen (AMGN) Advances While Market Declines: Some Information for Investors Zacks

2 days Sana Biotech’s islet cell therapy shows promise in diabetes; shares surge 150% postmarket Investing.com

2 days Top 5 Commercial Biotech Buyout Candidates: Legend Biotech (No. 4) Seeking Alpha

2 days Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5) Seeking Alpha

2 days Sanofi Down 10% in 3 Months: How Should You Play the Stock? Zacks

3 days Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report? Zacks

3 days Huge New Year’s Insider Buying From Warren Buffett and Others 24/7 Wall St.

3 days AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell? Zacks

5 days A successful VC predicts what the next 10 years in the venture capital industry will look like Business Insider

6 days Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors Zacks

6 days Here’s Why Arcutis Stock More Than Doubled in Market Value in One Year Zacks

6 days Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It Zacks

7 days Final Trade: XLE, PANW, XHB, BMY YouTube

7 days Looks Like Tech will lead this year again. Reddit

1 week Neumora Therapeutics’ stock craters after trial of major depressive disorder fails to meet main goals MarketWatch

1 week MNPR Stock Skyrockets 384% in 3 Months After Deal With AZN Zacks

1 week 5 Large Drug Stocks to Keep An Eye On in the New Year Zacks

1 week Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? Zacks

1 week All You Need to Know About Puma Biotech (PBYI) Rating Upgrade to Strong Buy Zacks

1 week Amgen (AMGN) Advances While Market Declines: Some Information for Investors Zacks

1 week 2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensive Fast Company

1 week Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now? Zacks

1 week This Biotech Is One of the S&P 500’s Worst Performers. It Looks Too Cheap. Yahoo Finance

1 week Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights Zacks

1 week Bristol-Myers Squibb Stock: Clearly Undervalued, Excellent 2H24 Culminates In Opdivo ‘Subcu’ Approval Seeking Alpha

1 week Friday’s Insider Activity: Top Execs Make Moves in Biotech and Retail Investing.com

2 weeks Buffett Is Still Buying, Plus Insiders Love These 2 Biotech Stocks 24/7 Wall St.

2 weeks Bristol Myers Squibb (BMY) Stock Moves -0.55%: What You Should Know Zacks

2 weeks Krystal Biotech: Blockbuster Ambitions For Topical Gene Therapy Seeking Alpha

2 weeks How Tarsus Pharmaceuticals’ Unique Inspiration Is Driving A Triple-Digit Run Investor's Business Daily

2 weeks Is Bristol Myers Squibb (BMY) Stock Undervalued Right Now? Zacks

2 weeks 2025 Analyst Outlook: Edmund Ingham On Biotech Big And Small, And A Key Milestone Seeking Alpha

2 weeks 4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow Zacks

2 weeks BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer Zacks

2 weeks Should You Invest in the VanEck Biotech ETF (BBH)? Zacks

2 weeks Here’s Why Amgen (AMGN) Gained But Lagged the Market Today Zacks

2 weeks 5 Biotech Breakthrough Stocks to Watch in 2025 Zacks

2 weeks Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Zacks

2 weeks Investors optimistic about continued biotech and medtech IPO resurgence in 2025 Yahoo Finance

3 weeks This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy? Yahoo Finance

3 weeks Bristol-Myers Squibb: Rich Dividends & Double-Digits Upside Potential – Bright 2026 Prospects Seeking Alpha

3 weeks Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold? Zacks

3 weeks Bristol-Myers Squibb Will Handle The Patent Cliff And Is Still Undervalued Seeking Alpha

3 weeks Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today Zacks

3 weeks Bristol Myers Squibb Stock Earns 83 RS Rating Investor's Business Daily

3 weeks 4 Biotech Stocks Most Wall Street Analysts Are Bullish About Zacks

3 weeks KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707 Zacks